BioLASCO Taiwan Co., Ltd.
BioLASCO Taiwan Co., Ltd. operates an animal breeding center to produce specific pathogen-free laboratory mice and rats in Taiwan and internationally. It offers lab animals, such as rat, mice, and others, as well as surgical services; rodents housing, washing solutions, workstations, animal housing and management solutions, lab animal research equipment, clean solution, preclinical imaging system… Read more
Market Cap & Net Worth: BioLASCO Taiwan Co., Ltd. (6662)
BioLASCO Taiwan Co., Ltd. (TWO:6662) has a market capitalization of $8.62K (NT$285.28K) as of March 18, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #45135 globally and #2003 in its home market, demonstrating a -0.17% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BioLASCO Taiwan Co., Ltd.'s stock price NT$29.90 by its total outstanding shares 9541 (9.54K).
BioLASCO Taiwan Co., Ltd. Market Cap History: 2025 to 2026
BioLASCO Taiwan Co., Ltd.'s market capitalization history from 2025 to 2026. Data shows growth from $8.94K to $8.62K (0.00% CAGR).
BioLASCO Taiwan Co., Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BioLASCO Taiwan Co., Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 6662 by Market Capitalization
Companies near BioLASCO Taiwan Co., Ltd. in the global market cap rankings as of March 18, 2026.
Key companies related to BioLASCO Taiwan Co., Ltd. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
BioLASCO Taiwan Co., Ltd. Historical Marketcap From 2025 to 2026
Between 2025 and today, BioLASCO Taiwan Co., Ltd.'s market cap moved from $8.94K to $ 8.62K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$8.62K | -3.55% |
| 2025 | NT$8.94K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of BioLASCO Taiwan Co., Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.62K USD |
| MoneyControl | $8.62K USD |
| MarketWatch | $8.62K USD |
| marketcap.company | $8.62K USD |
| Reuters | $8.62K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.